These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2905651

  • 1. Tardive dyskinesia. Pathophysiological mechanisms and clinical trials.
    Gerlach J.
    Encephale; 1988 Sep; 14 Spec No():227-32. PubMed ID: 2905651
    [Abstract] [Full Text] [Related]

  • 2. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
    Psychopharmacology (Berl); 1986 Sep; 90(4):423-9. PubMed ID: 2880362
    [Abstract] [Full Text] [Related]

  • 3. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV, Wyatt RJ.
    J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
    [Abstract] [Full Text] [Related]

  • 4. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [Abstract] [Full Text] [Related]

  • 5. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P, Bathien N.
    Adv Neurol; 1987 Nov; 45():361-6. PubMed ID: 2881446
    [No Abstract] [Full Text] [Related]

  • 6. Pathophysiological mechanisms underlying tardive dyskinesia.
    Gerlach J.
    Psychopharmacology Suppl; 1985 Nov; 2():98-103. PubMed ID: 2860666
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
    Lambert PA, Cantiniaux P, Chabannes JP, Tell GP, Schechter PJ, Koch-Weser J.
    Encephale; 1982 Nov; 8(3):371-6. PubMed ID: 6137357
    [Abstract] [Full Text] [Related]

  • 8. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA, Gautier J.
    Encephale; 1987 Nov; 13(5):301-8. PubMed ID: 2892663
    [Abstract] [Full Text] [Related]

  • 9. Gamma-Acetylenic GABA in tardive dyskinesia.
    Casey DE, Gerlach J, Magelund G, Christensen TR.
    Adv Biochem Psychopharmacol; 1980 Nov; 24():577-80. PubMed ID: 6105803
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [Abstract] [Full Text] [Related]

  • 11. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE.
    J Clin Psychiatry; 2000 Apr; 61 Suppl 4():5-9. PubMed ID: 10739324
    [Abstract] [Full Text] [Related]

  • 12. Tardive dyskinesia.
    Gerlach J, Casey DE.
    Acta Psychiatr Scand; 1988 Apr; 77(4):369-78. PubMed ID: 2898870
    [Abstract] [Full Text] [Related]

  • 13. Neuroleptic medication facilitates the natural occurrence of tardive dyskinesia. A critical review.
    Driesens F.
    Acta Psychiatr Belg; 1988 Apr; 88(3):195-205. PubMed ID: 2906780
    [Abstract] [Full Text] [Related]

  • 14. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
    Inada T, Koga M, Ishiguro H, Horiuchi Y, Syu A, Yoshio T, Takahashi N, Ozaki N, Arinami T.
    Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
    [Abstract] [Full Text] [Related]

  • 15. [Neuroleptics and nicotine].
    Erdmann R.
    Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
    [Abstract] [Full Text] [Related]

  • 16. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
    Bathien N, Rondot P, Koutlidis RM.
    J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
    [Abstract] [Full Text] [Related]

  • 17. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S, Sandmann U, Genz A.
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [Abstract] [Full Text] [Related]

  • 18. The pathophysiologic basis of tardive dyskinesia.
    Tarsy D, Baldessarini RJ.
    Biol Psychiatry; 1977 Jun; 12(3):431-50. PubMed ID: 194633
    [Abstract] [Full Text] [Related]

  • 19. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM, Annable L, Bélanger MC, Chouinard G.
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [Abstract] [Full Text] [Related]

  • 20. The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia.
    Malik P, Andersen MB, Peacock L.
    Pharmacol Biochem Behav; 2004 Aug; 78(4):805-10. PubMed ID: 15301939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.